1. Home
  2. OVLY vs EDIT Comparison

OVLY vs EDIT Comparison

Compare OVLY & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oak Valley Bancorp (CA)

OVLY

Oak Valley Bancorp (CA)

N/A

Current Price

$32.90

Market Cap

269.7M

Sector

Finance

ML Signal

N/A

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

N/A

Current Price

$2.63

Market Cap

206.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OVLY
EDIT
Founded
1990
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
269.7M
206.0M
IPO Year
2008
2016

Fundamental Metrics

Financial Performance
Metric
OVLY
EDIT
Price
$32.90
$2.63
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$4.50
AVG Volume (30 Days)
15.7K
1.4M
Earning Date
04-27-2026
06-08-2026
Dividend Yield
2.31%
N/A
EPS Growth
N/A
37.50
EPS
2.12
N/A
Revenue
N/A
$31,937,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.29
N/A
Revenue Growth
N/A
132.64
52 Week Low
$22.70
$0.91
52 Week High
$34.16
$4.54

Technical Indicators

Market Signals
Indicator
OVLY
EDIT
Relative Strength Index (RSI) 53.19 67.18
Support Level $32.81 $2.42
Resistance Level $34.08 $2.76
Average True Range (ATR) 0.71 0.19
MACD -0.13 0.06
Stochastic Oscillator 51.55 87.67

Price Performance

Historical Comparison
OVLY
EDIT

About OVLY Oak Valley Bancorp (CA)

Oak Valley Bancorp is a bank holding company that operates through Oak Valley Community Bank (the Bank). The Bank offers a complement of business checking and savings accounts for its business customers. The Bank also offers commercial and real estate loans, as well as lines of credit. In addition, the bank provides other services for both individuals and businesses including online banking, remote deposit capture, mobile banking, merchant services, night depository, extended hours, wire transfer of funds, note collection, and automated teller machines in a national network. Its primary source of revenue is net interest income.

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

Share on Social Networks: